Venous Thrombosis Mouse Model
Venous Thrombosis Mouse Model - Related Videos
06:03
Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis
0 Views •
Cited by 39 •
2011
The electrolytic induction of endothelial activation to the internal surface of the Inferior Vena Cava results in venous type thrombus formation due to endothelial activation and partial blood stasis, two components of Virchow's triad.
04:40
Venous Thrombosis Assay in a Mouse Model of Cancer
0 Views •
2024
This article aims to present an optimized method for assessing venous thrombosis in a mouse cancer model, using vascular clips to achieve venous ligation. Optimization minimizes variability in thrombosis-related measurements and enhances relevance to human cancer-associated venous thrombosis.
04:34
Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
0 Views •
Cited by 28 •
2011
The mouse complete stasis model of inferior vena cava thrombosis yields quantifiable amounts of vein wall tissue and thrombus. It has proven useful for evaluating interactions between the vein wall and the occlusive thrombus and in assessing the progression from acute to chronic inflammation.
01:30
Venous Thrombosis I: Introduction
0 Views •
2025
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
08:27
Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.
0 Views •
Cited by 13 •
2015
We describe a method for creating a reliable model of cerebral venous hypertension in the adult mouse. This model has been widely described and tested in the rat. This new counterpart in the mice opens the possibility of using genetic modified animals and thereby broadens the applications of the model.
FAQs
Partial restriction or ligation of the inferior vena cava creates disturbed venous flow, which promotes a coordinated thrombotic response. This condition supports endothelial activation, recruitment of platelets and leukocytes, and activation of coagulation. Studying these linked events helps researchers examine how vascular tissues and blood cells interact during the development of venous thromboembolism.
The model brings several components of thrombosis into the same experimental setting. Endothelial activation affects the vascular surface, while recruited platelets and leukocytes contribute to clot development alongside coagulation activity. Examining these components together allows investigators to study thrombosis as an interaction among blood cells, vascular tissues, and inflammatory pathways rather than as an isolated coagulation event.
Researchers can use the induced venous thrombus to examine how risk factors influence clot formation and how inflammatory pathways participate in that process. Because the model permits assessment of thrombus incidence, size, and composition, investigators can relate biological changes to measurable clot outcomes. This supports mechanistic studies of thrombosis development and factors that may affect recurrence.
Thrombus size alone does not capture the full behavior of a venous clot. Assessing composition provides information about the cellular and vascular elements associated with formation, while monitoring resolution shows how the thrombus changes over time. Together with incidence, these outcomes help investigators evaluate both clot development and clearance, including responses relevant to prevention and treatment.
A basic workflow involves inducing venous thrombosis by partially restricting or ligating the inferior vena cava, then examining the resulting thrombus. Investigators can measure whether thrombosis occurs and assess its size, composition, and resolution. These measurements provide a structured way to connect the imposed change in venous flow with cellular, vascular, and inflammatory responses.
Researchers use this system for preclinical evaluation of anticoagulants and other potential therapies. After thrombosis is induced, treatment-related differences can be examined through outcomes such as thrombus incidence, size, composition, or resolution. The model therefore helps determine whether an intervention affects clot formation or subsequent thrombus behavior before its relevance is considered in broader medical research.
In medicine, the model supports investigation of venous thromboembolism across several stages, including development, prevention, treatment, and recurrence. Its outcome measures allow researchers to study how clots form, change, and resolve while considering interactions between blood cells, vascular tissues, and inflammatory pathways. This broader context helps connect mechanistic findings with clinically relevant thrombosis research.